0QF:ETR
Moderna Inc
179,48 €
arrow_upward
+1,49%(+2,64) 1D
6. lis, 14:01:48 GMT+2 · EUR
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za 0QF...
Otvori
183,54 €
Najviša
184,06 €
Najniža
178,80 €
Trž. kap.
81,13 mlr.
Prosj. kol.
31,26 tis.
Količina
14,22 tis.
52-tjed. najviša
184,20 €
52-tjed. najniža
19,37 €
Broj djelatnika
5 tis.
Otvori
183,54 €
Najviša
184,06 €
Najniža
178,80 €
Trž. kap.
81,13 mlr.
Prosj. kol.
31,26 tis.
Količina
14,22 tis.
52-tjed. najviša
184,20 €
52-tjed. najniža
19,37 €
Broj djelatnika
5 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
Seeking Alpha
·
prije 1 sat
Novavax, Moderna cool as WHO downplays plague-related death in Russia
AD HOC NEWS
·
prije 1 sat
Nasdaq adds Moderna to Nasdaq-100 and lifts visibility for Moderna stock
The Daily Free Press
·
prije 8 sati
The ‘Edison of Medicine’: Moderna founder visits BU for Q&A event, shares encouragement, life experience
Stock Titan
·
prije 13 sati
Moderna (MRNA) COO Juan Andres reports direct ownership of 125,000 common shares.
Profil
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
Moderna Inc – informacije
Glavni izvršni direktorStéphane Bancel
Zaposlenici4,7 tis.
Osnovanoruj 2010
Sjedište-
Sektor-
Web-lokacijamodernatx.com